US 11673967
Stabilized formulations containing anti-PCSK9 antibodies
granted A61KA61K39/3955A61K39/39591
Quick answer
US patent 11673967 (Stabilized formulations containing anti-PCSK9 antibodies) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jun 08 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Jun 13 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 08 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K39/3955, A61K39/39591, A61K47/22, A61K47/26